Literature DB >> 18594841

Outcome of patients with clinical stage II or III rectal cancer treated without adjuvant radiotherapy.

Shin Fujita1, Seiichiro Yamamoto, Takayuki Akasu, Yoshihiro Moriya.   

Abstract

BACKGROUND: To clarify the indications for preoperative adjuvant radiotherapy for rectal cancer, the outcome of patients who underwent curative surgery without adjuvant radiotherapy was investigated.
METHODS: A total of 817 consecutive patients who underwent curative surgery for clinical stage II or III rectal cancer without preoperative adjuvant radiotherapy between 1988 and 2002 were reviewed.
RESULTS: The actuarial 5-year local recurrence rate in the examined patients was 6.2%. Univariate analysis showed that sex, pathological T classification (pT), clinical N classification (cN), pathological N classification (pN), tumor site, distance from the anal verge, type of surgery, pathological stage, a positive radical margin, lymphatic invasion, and venous invasion were significantly correlated with local recurrence. Multivariate analysis of preoperative factors identified cN, distance from the anal verge, and sex as statistically significant risk factors for local recurrence. In patients with rectal cancer located less than 5 cm from the anal verge and with positive cN, the local recurrence rate was more than 10%.
CONCLUSIONS: Patients with rectal cancer located less than 5 cm from the anal verge and with clinically positive lymph nodes should be given preoperative adjuvant radiotherapy.

Entities:  

Mesh:

Year:  2008        PMID: 18594841     DOI: 10.1007/s00384-008-0513-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  29 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Chemotherapy with preoperative radiotherapy in rectal cancer.

Authors:  Jean-François Bosset; Laurence Collette; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Jean-Claude Ollier
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

3.  Long-term effect of preoperative radiation therapy on anorectal function.

Authors:  Johan Pollack; Torbjörn Holm; Björn Cedermark; Bo Holmström; Anders Mellgren
Journal:  Dis Colon Rectum       Date:  2006-03       Impact factor: 4.585

4.  Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.

Authors:  Wai Lun Law; Judy W C Ho; Raymond Chan; Gordon Au; Kin Wah Chu
Journal:  Dis Colon Rectum       Date:  2005-02       Impact factor: 4.585

Review 5.  Should preoperative or postoperative therapy be administered in the management of rectal cancer?

Authors:  Lisa A Kachnic
Journal:  Semin Oncol       Date:  2006-12       Impact factor: 4.929

6.  Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.

Authors:  Corrie A M Marijnen; Cornelis J H van de Velde; Hein Putter; Mandy van den Brink; Cornelis P Maas; Hendrik Martijn; Harm J Rutten; Theo Wiggers; Elma Klein Kranenbarg; Jan-Willem H Leer; Anne M Stiggelbout
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

7.  Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.

Authors:  Morten T Eriksen; Arne Wibe; Jon Haffner; Johan N Wiig
Journal:  Dis Colon Rectum       Date:  2007-02       Impact factor: 4.585

8.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Authors:  Jean-Pierre Gérard; Thierry Conroy; Franck Bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

9.  Is pre-operative radiotherapy necessary in T-T rectal cancer with TME?

Authors:  G Mackay; M Downey; R G Molloy; P J O'Dwyer
Journal:  Colorectal Dis       Date:  2006-01       Impact factor: 3.788

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  9 in total

1.  Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer: is it beneficial?

Authors:  Jin Soo Kim; Nam Kyu Kim; Byung Soh Min; Hyuk Hur; Joong Bae Ahn; Ki Chang Keum
Journal:  Int J Colorectal Dis       Date:  2010-06-11       Impact factor: 2.571

2.  Improving prediction of lateral node spread in low rectal cancers--multivariate analysis of clinicopathological factors in 1,046 cases.

Authors:  Kok-Yang Tan; Seiichiro Yamamoto; Shin Fujita; Takayuki Akasu; Yoshihiro Moriya
Journal:  Langenbecks Arch Surg       Date:  2010-04-02       Impact factor: 3.445

3.  Clinical characteristics of rectal cancer involving the anal canal.

Authors:  Mitsuyoshi Ota; Shoichi Fujii; Yasushi Ichikawa; Hirokazu Suwa; Kenji Tatsumi; Kazuteru Watanabe; Kuniya Tanaka; Hirotoshi Akiyama; Itaru Endo
Journal:  J Gastrointest Surg       Date:  2010-11-30       Impact factor: 3.452

4.  Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.

Authors:  Paul Hermanek; Susanne Merkel; Rainer Fietkau; Claus Rödel; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2009-12-10       Impact factor: 2.571

5.  Case-matched comparison of the short-term outcomes between laparoscopic and open abdominoperineal resection for rectal cancer.

Authors:  Ryo Inada; Seiichiro Yamamoto; Taihei Oshiro; Masashi Takawa; Shin Fujita; Takayuki Akasu
Journal:  Surg Today       Date:  2013-05-14       Impact factor: 2.549

6.  A prospective feasibility study to evaluate neoadjuvant-synchronous S-1 with radiotherapy for locally advanced rectal cancer: A multicentre phase II trial.

Authors:  Masafumi Inomata; Tomonori Akagi; Kentaro Nakajima; Tsuyoshi Etoh; Koichiro Tahara; Toshifumi Matsumoto; Tadashi Ogawa; Kyuzo Fujii; Akio Shiromizu; Seigo Kitano
Journal:  Mol Clin Oncol       Date:  2016-02-04

7.  Pathological complete response after preoperative chemotherapy including FOLFOX plus bevacizumab for locally advanced rectal cancer: A case report and literature review.

Authors:  Ryoichi Miyamoto; Kazunori Kikuchi; Atsushi Uchida; Masayoshi Ozawa; Naoki Sano; Sosuke Tadano; Satoshi Inagawa; Tatsuya Oda; Nobuhiro Ohkohchi
Journal:  Int J Surg Case Rep       Date:  2019-08-17

8.  Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.

Authors:  Liming Wang; Yasumitsu Hirano; Toshimasa Ishii; Hiroka Kondo; Kiyoka Hara; Nao Obara; Shigeki Yamaguchi
Journal:  World J Surg Oncol       Date:  2020-03-11       Impact factor: 2.754

Review 9.  Mechanisms and Clinical Significance of Tumor Lymphatic Invasion.

Authors:  Noriki Fujimoto; Lothar C Dieterich
Journal:  Cells       Date:  2021-09-29       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.